However, there are many alterations shared among different PTCL subtypes, including alterations involving TCR/NF-κB and JAK/STAT pathway molecules, epigenetic regulators, immune-associated molecules, and tumor suppressors. The gene discussed is NFKB1; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.